Related Experiment Video
Updated: Oct 7, 2025

09:28
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
Published on: November 17, 2018
11.8K
Magnetic Nanoparticles with Surface Nanopockets for Highly Selective Antibody Isolation.
D Randil K Weerasuriya1, Snehasis Bhakta1,2, Keshani Hiniduma1
1Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269-3060, United States.
ACS Applied Bio Materials
|January 10, 2022
Summary
Researchers developed low-cost, reusable magnetic nanoparticles with Protein A-like nanopockets for efficient antibody purification. This innovation significantly reduces the cost of antibody-based therapies and diagnostics.
Area of Science:
- Biotechnology
- Materials Science
- Immunology
Background:
- Monoclonal antibodies (mAbs) are crucial for immunotherapies, diagnostics, and imaging.
- High costs, particularly in purification, limit mAb accessibility.
- Current Protein A (PrA) resins face challenges in cost, efficiency, and stability.
Purpose of the Study:
- To synthesize cost-effective, reusable, and stable Protein A-like nanopockets on magnetic nanoparticles (NPs) for IgG antibody isolation.
- To mimic the binding capabilities of PrA for improved antibody purification.
Main Methods:
- Core-shell silica-coated magnetic nanoparticles were functionalized with IgG antibodies in a stem-down orientation.
- Polymerization using silane monomers created a coating mimicking PrA binding interactions.
- NPs were regenerated for multiple purification cycles.
Main Results:
- Synthesized nanopocket NPs demonstrated IgG binding characteristics similar to PrA.
- Rougher NPs exhibited significantly higher IgG binding capacities and selectivity compared to commercial PrA magnetic beads.
- The developed NPs maintained performance over at least 15 regeneration cycles.
Conclusions:
- This study presents the first IgG-binding NPs engineered to mimic PrA selectivity.
- The novel nanopocket NPs offer a highly efficient and cost-effective alternative for antibody purification.
- This advancement has the potential to reduce the cost of mAb-based therapies and diagnostics significantly.

